marijuana stock news

Form 8-K for NUVILEX, INC.

9-Jan-2015

Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation FD Disc

Item 5.03 Amendments to Articles of Incorporation or BylawsEffective January 6, 2015, Nuvilex, Inc. (“Company”) changed its legal corporate name to “PharmaCyte Biotech, Inc.” The name change was effected through a short-form merger pursuant to Section 92A.180 of the Nevada Revised Statutes. A wholly-owned subsidiary of the Company was merged with and into the Company, with the Company as the surviving entity of the merger. The merger had the effect of amending the Company’s Certificate of Incorporation to reflect the new legal name of the Company. A copy of the Articles of Merger effecting the name change, as filed with the Secretary of State of the State of Nevada, is attached hereto as Exhibit 3.1. The Articles of Merger became effective by their terms on January 6, 2015.

In connection with the name change, the Company also changed the ticker symbol of its common stock, which previously traded under the ticker symbol “NVLX.” The Company’s common stock is trading under the ticker symbol “PMCB.”

The merger and resulting name change do not affect the rights of the Company’s security holders, creditors, customers or suppliers. With the exception of the name change, there were no changes to the Company’s Certificate of Incorporation or Bylaws.

Item 7.01. Regulation FD DisclosureOn January 7, 2015, the Company issued a press release announcing the name change, a copy of which is attached hereto as Exhibit 99.1. On January 8, 2015, the Company issued a press release announcing the new ticker symbol, a copy of which is attached hereto as Exhibit 99.2. The information furnished in this Item 7.01, including Exhibits 99.1 and 99.2, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section.

Item 9.01 Financial Statements and Exhibits.(d) Exhibits.

3.1 Articles of Merger merging PharmaCyte Biotech, Inc. with and into Nuvilex, Inc., effective January 6, 2015
99.1 Press Release dated January 7, 2015
99.2 Press Release dated January 8, 2015


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
1 comment
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Reliq Health Technologies Inc. (RQHTF) Announces Closing of Oversubscribed Non-Brokered Private Placement

Reliq Health Announces Closing of Oversubscribed Non-Brokered Private Placement with Gravitas Securities…

 Village Farms International, Inc. (VFF) to Host Second Quarter 2020 Conference Call on Thursday 

Village Farms International to Host Second Quarter 2020 Conference Call on Thursday,…

$PMCB New Research Shows Melligen Cell Line Can Reverse Diabetes

New Research Shows PharmaCyte Biotech’s Melligen Cell Line Can Reverse Diabetes Diabetes…

Future Farm Technologies Inc. (FFRMF) Announces $500,000 Line of Credit and Shareholder Conference Call

Future Farm Announces $500,000 Line of Credit and Shareholder Conference Call  Future…